Review of Adverse Drug Reactions of Medicines used for the Treatment of Benign Prostatic Hyperplasia Reported to Halmed

Benign prostatic hyperplasia is one of the most common diseases in men, with a prevalence rate of 50% in their 50s to 80% in their 80s, and is mostly treated with chronic drug therapy. The aim of this study was to analyze adverse drug reactions (ADR) to drugs used in benign prostate hyperplasia (...

Full description

Bibliographic Details
Main Authors: Iva Kuliš, Željana Margan Koletić, Tvrtko Hudolin, Siniša Tomić
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2023-01-01
Series:Acta Clinica Croatica
Subjects:
Online Access:https://hrcak.srce.hr/file/446358